Mortality in the early ART treatment period is higher among patients with low BMI, low CD4+ T-cell counts, low hemoglobin, low serum albumin and phosphate levels, advanced HIV/AIDS stage, and immune reconstitution inflammatory syndrome [3–5]. Here, CD4 is linked to AIDS.